Infinitopes Raises $35 Million to Propel Cancer Vaccine Development and Transform Patient Care Infinitopes has successfully raised a total of $35.1 million in seed funding, aimed at advancing its promising cancer vaccine ITOP1 towards clinical trials, targeting oesophageal cancer.

Infinitopes Raises $35 Million to Propel Cancer Vaccine Development and Transform Patient Care #United_Kingdom #Oxford #Cancer_Vaccine #Infinitopes #ITOP1

Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK Infinitopes Ltd has received UK regulatory approval to commence clinical trials for ITOP1, a novel vaccine targeting oesophageal cancer, showing promise in reducing recurrence rates.

Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK #United_Kingdom #Oxford #Infinitopes #Oesophageal_Cancer #ITOP1